IPH 2101
- Generic Name
- IPH 2101
- Drug Type
- Biotech
- CAS Number
- 1000676-42-5
- Unique Ingredient Identifier
- 5Q686XLG8L
- Background
IPH-2101 (NN-1975), a fully human monoclonal antibody developed for patients with acute myeloid leukemia.
- Indication
Investigated for use/treatment in leukemia (myeloid) and multiple myeloma.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath